CORP CONNECT (OCTOBER 2024, EDITION)

November 18, 2024
CORP CONNECT (OCTOBER 2024, EDITION) - Newsletter Image

More Articles

  1. Two Frontiers of Pharmaceutical Exclusivity: What Retatrutide and Semaglutide Tell Us About Protecting a Drug Across Its Lifecycle
  2. Registration Is Not Immunity: The Kerala High Court’s Trade Mark Lesson in M. Manuel v. Malabar Gold
  3. Biological Material Patents in India: Why a Pending NBA Application Should Not Mean Refusal
  4. AI in Patent Examination: Inside India’s New Guidelines from the CGPDTM
  5. Mobile Phone Manufacturing Scheme (MPMS): India’s Next Leap in Electronics Manufacturing
  6. CGPDTM Issues Guidelines for the Use of Artificial Intelligence in Patent Examination Procedures
For more information please contact us at : info@ssrana.com